13F filer · CIK 1802630
Soleus Capital Management, L.P.
GREENWICH, CT · filing since Q4 2019 · last filing Aug 11, 2026
Reported value
$2.9B
+$432.8M vs prior
Positions
97
New / sold out
22 / 18
Added / reduced
25 / 41
Turnover
29.0%
buys $777.5M · sells $927.7M
Top-10 weight
48.9%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | INSULET CORP | +486,500 | +86.5% | +$74.1M |
| Added | RIGEL PHARMACEUTICALS INC | +1,833,504 | +18335.0% | +$71.7M |
| Added | INSPIRE MED SYS INC | +1,355,137 | +235.1% | +$60.5M |
| New | ERASCA INC | +2,700,000 | – | +$49.5M |
| Added | CELCUITY INC | +419,940 | +32.7% | +$43.9M |
| New | PARABILIS MEDICINES INC | +1,465,070 | – | +$40.1M |
| New | LEGEND BIOTECH CORP | +1,205,000 | – | +$34.8M |
| New | UNITEDHEALTH GROUP INC | +80,000 | – | +$33.3M |
| New | PALISADE BIO INC | +13,063,687 | – | +$27.3M |
| New | SUPERNUS PHARMACEUTICALS | +520,000 | – | +$24.2M |
37 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | TWIST BIOSCIENCE CORP | -1,122,000 | -91.5% | $-115.4M |
| Reduced | KRYSTAL BIOTECH INC | -213,833 | -18.5% | $-79.5M |
| Reduced | TG THERAPEUTICS INC | -1,101,424 | -27.3% | $-60.5M |
| Reduced | PRAXIS PRECISION MEDICINES I | -153,000 | -46.3% | $-51.2M |
| Reduced | ALKERMES PLC | -941,612 | -47.8% | $-49.3M |
| Reduced | VERICEL CORP | -1,089,927 | -42.8% | $-48.5M |
| Reduced | EDGEWISE THERAPEUTICS INC | -999,026 | -68.9% | $-40.6M |
| Reduced | MIRUM PHARMACEUTICALS INC | -325,306 | -81.3% | $-38.1M |
| Reduced | NATERA INC | -118,000 | -99.2% | $-32.0M |
| Reduced | ALNYLAM PHARMACEUTICALS INC | -98,600 | -74.9% | $-29.7M |
49 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | KRYSTAL BIOTECH INCCOM | 939,254 | $349.1M | 12.03% |
| 2 | CELCUITY INCCOM | 1,704,318 | $178.3M | 6.14% |
| 3 | TG THERAPEUTICS INCCOM | 2,927,895 | $160.9M | 5.54% |
| 4 | INSULET CORPCOM | 1,049,000 | $159.7M | 5.50% |
| 5 | NOVOCURE LTDORD SHS | 9,913,401 | $150.2M | 5.18% |
| 6 | UNITED THERAPEUTICS CORP DELCOM | 225,587 | $122.2M | 4.21% |
| 7 | INSPIRE MED SYS INCCOM | 1,931,436 | $86.2M | 2.97% |
| 8 | RIGEL PHARMACEUTICALS INCCOM | 1,843,504 | $72.1M | 2.49% |
| 9 | ANI PHARMACEUTICALS INCCOM | 867,760 | $71.8M | 2.48% |
| 10 | BETA BIONICS INCCOM | 4,393,714 | $68.8M | 2.37% |
87 more rows. Subscribe for $29/month to see every row, download the data and use the API.